Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.
暂无分享,去创建一个
R. Eliakim | U. Kopylov | B. Weiss | Y. Mazor | I. Dotan | R. Shamir | L. Lichtenstein | S. Ben-Horin | A. Levine | A. Assa | H. Yanai | Y. Ron | Y. Chowers | Y. Bujanover | G. Fraser | B. Ungar | Y. Rosenbach